Celdoxome pegylated liposomal doxorubicin hydrochloride

doxorubicin hydrochloride · Baxter Holding B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Celdoxome pegylated liposomal doxorubicin hydrochloride, covering 2025-11-27 to 2025-11-27. Get the full timeline:

Most recent: EMA Lapsed: Celdoxome pegylated liposomal (doxorubicin hydrochloride) — Baxter Holding B.V.

See pricing